Monday - April 6, 2026
HKUMed discovers expanded use of fatty liver drug for preventing and suppressing liver cancer
March 24, 2026
HONG KONG, March 24 -- The University of Hong Kong issued the following news release:

* * *

HKUMed discovers expanded use of fatty liver drug for preventing and suppressing liver cancer

*

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the HKU State Key Laboratory of Liver Research, has found that Resmetirom, a drug approved by . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products